Sunday, August 26, 2012

Merck to pursue approval for vorapaxar in prior MI patients

Merck has announced that it is going to pursue approval for the antiplatelet agent vorapaxar in patients with prior MI and no history of stroke or TIA.

via The Heart

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)